The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice.

by Sih Min Tan, Arpeeta Sharma, Derek Y C Yuen, Nada Stefanovic, Guy Krippner, Govindasamy Mugesh, Zhonglin Chai, Judy B de Haan
Published 2013-01-01